Baxter Healthcare Corp. to Upgrade Glendale Property
- Share via
Baxter Healthcare Corp. in Glendale said it plans to invest $400 million to expand and upgrade its facilities to increase production capacity for biopharmaceuticals and vaccines.
The company recently began construction on a new $100-million, plasma-processing facility located next to its Hyland Immuno facility in Los Angeles.
Baxter develops and produces therapeutic proteins from plasma to treat hemophilia, immune deficiencies and other blood-related disorders. It is the principal U.S. operating subsidiary of Baxter International Inc.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
